Andrew Davis
SVP, Chief Business Officer · IRONWOOD PHARMACEUTICALS INC
- 2024
- Nov 20, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Davis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alexander J. Denner - $20.53M in IRWD purchases and sales in the last 12 months
- Ronald Silver - $831K in IRWD purchases and sales in the last 12 months
- Thomas A. McCourt - $740K in IRWD purchases and sales in the last 12 months
- Minardo John - $136K in IRWD purchases and sales in the last 12 months
- Michael Shetzline - $122K in IRWD purchases and sales in the last 12 months
- Tammi L. Gaskins - $100K in IRWD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Davis?
Andrew Davis is a corporate insider, tracked as SVP, Chief Business Officer of IRONWOOD PHARMACEUTICALS INC (IRWD). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Andrew Davis last file a Form 4?
The only primary Form 4 on record is dated 20 November 2024.
Has Andrew Davis been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($22K) across all tracked filings.
